Age, years
|
28.0 (25.0, 31.0)
|
29.0 (26.0, 32.0)
|
26.0 (23.0, 29.5)
|
0.011
|
Body mass index, kg/m2
|
25.2 (23.4, 26.6)
|
24.7 (23.7, 27.9)
|
25.4 (23.3, 26.0)
|
0.71
|
Systolic blood pressure, mmHg
|
126.0 (112.0, 139.0)
|
129.0 (119.5, 142.0)
|
124.0 (110.0, 138.0)
|
0.25
|
Diastolic blood pressure, mmHg
|
80.0 (70.0, 90.0)
|
81.5 (71.5, 90.5)
|
75.5 (69.5, 92.5)
|
0.38
|
Mean arterial pressure, mmHg
|
94.3 (83.7, 106.7)
|
98.8 (87.8, 107.7)
|
90.7 (83.5, 107.8)
|
0.34
|
History of pregnancy
| | | | |
First-time pregnancy (%)
|
33 (45.2)
|
17 (44.7)
|
16 (45.7)
|
0.82
|
Adverse pregnancy history (%)
|
20 (27.4)
|
12 (31.63)
|
8 (22.9)
|
0.62
|
Duration of SLE diagnosis to pregnancy, years
|
-
|
7 (4.0, 10.0)
|
-
|
-
|
Duration of LN diagnosis to pregnancy, years
|
-
|
6 (2.0, 9.3)
|
-
|
-
|
Treatment during pregnancy (%)
| | | | |
Prednisone and immunosuppressant
|
11 (15.1)
|
10 (26.3)
|
1 (2.9)
|
0.007
|
Prednisone alone
|
65 (89.0)
|
35 (92.1)
|
30 (85.7)
|
0.28
|
Treatment post pregnancy (%)
| | | | |
Prednisone and cyclophosphamide
|
20 (27.4)
|
9 (23.7)
|
11 (31.4)
|
0.40
|
Prednisone and methotrexate
|
5 (6.8)
|
1 (2.6)
|
4 (11.4)
|
0.18
|
Prednisone and calcineurin inhibitors
|
9 (12.3)
|
6 (15.8)
|
3 (8.6)
|
0.48
|
Prednisone and mycophenolate mofetil
|
8 (11.1)
|
4 (10.5)
|
4 (11.4)
|
0.86
|
Laboratory Values
| | | | |
Hemoglobin, g/L
|
91.0 (76.0, 108.0)
|
98.0 (81.0, 112.0)
|
85.0 (75.5, 103.5)
|
0.12
|
Platelet, ×109/L
|
179.0 (134.0, 257.0)
|
203.0 (137.0, 260.0)
|
173.0 (123.0, 239.0)
|
0.63
|
White blood cell, ×109/L
|
7.8 (5.5, 9.9)
|
8.8 (7.0, 10.8)
|
5.8 (4.3, 9.3)
|
0.012
|
Urea nitrogen, mg/dL
|
35.5 (21.0, 54.1)
|
34.9 (22.8, 55.9)
|
35.5 (19.8, 47.5)
|
0.64
|
Serum creatinine, mg/dL
|
0.8 (0.6, 1.1)
|
0.7 (0.6, 1.2)
|
0.8 (0.6, 1.1)
|
0.51
|
eGFR, mL/min/1.73 m2
|
106.0 (67.4, 124.9)
|
103.6 (63.6, 125.1)
|
108.5 (71.2, 124.9)
|
0.79
|
Serum albumin, g/dL
|
2.5 (2.1, 2.9)
|
2.3 (1.9, 2.9)
|
2.5 (2.2, 2.7)
|
0.44
|
Proteinuria, g/day
|
3.8 (2.0, 6.0)
|
4.5 (2.8, 5.1)
|
3.8 (2.0, 6.5)
|
0.93
|
> 3 red blood cells / high-power field (%)
|
49 (67.1)
|
24 (63.2)
|
25 (71.4)
|
0.29
|
> 5 white blood cells/ high-power field (%)
|
46 (63.0)
|
21 (55.3)
|
25 (71.4)
|
0.25
|